跳至主要内容
临床试验/CTRI/2018/02/012102
CTRI/2018/02/012102已完成2 期

A double blind, standard control clinical study with a herbal pain killer (PP/JLN/106/2009-10) in the management of menstrual pain (Dysmenorrhoea)

Dabur India Limited0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Female in the reproductive age group
  • 2. Females presenting with Dysmenorrhea with or without any of the following symptoms associated with mensturation:
  • a. Any kind of pain: headache, abdominal pain, bodyache
  • b. Nausea and Vomiting
  • c. Weakness
  • d. Psychological symptoms like anxiety, stress, depression, irritability, restlessness
  • e. irregular cycles
  • 3. Willingness to participate in the study and come for regular follow up as and when required
  • 4. Readiness to sign Informed Consent Form

排除标准

  • 1. Patients having organic causes of pain and menstrual abnormalities like uterine myeloma, adenomyosis, polyps, fibroids, endometriosis
  • 2. Patients suffering from systemic or metabolic disorders like pituitary disease, diabetes mellitus, thyroid dysfunction and coagulation disorders
  • 3. Patients having any other kind of chronic disease like respiratory or cardiac problems, HIV
  • 4. Subjects not willing to sign Informed Consent Form
  • 5. Patients participating in any other clinical study

研究者

相似试验